Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum
- PMID: 15691238
- DOI: 10.1111/j.1440-1843.2005.00659.x
Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum
Abstract
Objective: Inhaled mannitol increases mucus clearance in patients with bronchiectasis by an unclear mechanism. The effect of mannitol on lung function, health status and sputum properties was investigated.
Methodology: Nine patients with bronchiectasis inhaled 400 mg of mannitol once daily for 12 days. Health status was assessed using the St George's Respiratory Questionnaire (SGRQ). Sputum was analysed for viscosity, elasticity, spinnability, surface tension, contact angle, solids, mucociliary transportability (MCTR) on a frog palate, and cough transportability (CTR) on a simulated cough machine.
Results: Lung function was unchanged with treatment (baseline FEV1 82.0 +/- 16.2%) apart from an improvement in FEF from 85.4 +/- 13% (baseline) to 90.7 +/- 14.4% (P < 0.05; 12th treatment; visit 7). The total SGRQ score (mean +/- SD) of 49.3 +/- 13.8 at baseline, decreased by 12.4 +/- 10.2 (P < 0.01; visit 7) and 10.1 +/- 9.4 units (P < 0.02) 6-10 days after treatment cessation. The baseline subscores for symptoms (72.9 +/- 11.8), activity (44.7 +/- 20.9) and impact (44.4 +/- 14.3) were reduced by 0.8 +/- 9.1 (P > 0.7), 8.4 +/- 16.0 (P > 0.1) and 19.2 +/- 13.7 (P < 0.005) units, respectively (visit 7). Mannitol reduced the baseline (mean +/- SE) surface tension from 94.5 +/- 1.4 to 84.7 +/- 2.1 mN/m (P < 0.0001), contact angle from 51.1 +/- 2.8 to 33.2 +/- 2.4 degrees (P < 0.0001), spinnability from 11.6 +/- 0.4 to 10.0 +/- 0.2 mm (P < 0.005), and solids from 5.7 +/- 0.4 to 4.3 +/- 0.7% (P < 0.02), acutely (visit 7). Viscosity, elasticity and MCTR did not change significantly, while CTR was increased from 25.8 +/- 1.0 to 34.1 +/- 2.7 mm (P < 0.003).
Conclusion: Mannitol significantly improved the health status over 12 days and this improvement was maintained for 6-10 days after cessation of treatment. In addition, mannitol reduced the tenacity, increased the hydration of mucus acutely and improved cough clearability in patients with bronchiectasis.
Similar articles
-
Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.Respir Med. 2010 Nov;104(11):1645-53. doi: 10.1016/j.rmed.2010.05.019. Epub 2010 Jun 23. Respir Med. 2010. PMID: 20576419 Clinical Trial.
-
Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.Respir Med. 2010 Mar;104(3):371-7. doi: 10.1016/j.rmed.2009.10.021. Epub 2009 Nov 14. Respir Med. 2010. PMID: 19914814
-
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.Thorax. 2014 Dec;69(12):1073-9. doi: 10.1136/thoraxjnl-2014-205587. Epub 2014 Sep 21. Thorax. 2014. PMID: 25246664 Clinical Trial.
-
Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.Respirology. 2012 Aug;17(6):927-32. doi: 10.1111/j.1440-1843.2012.02189.x. Respirology. 2012. PMID: 22564014 Review.
-
Inhaled mannitol for the treatment of cystic fibrosis.Expert Rev Respir Med. 2012 Feb;6(1):19-26. doi: 10.1586/ers.11.87. Expert Rev Respir Med. 2012. PMID: 22283575 Review.
Cited by
-
Rheological effects of hypertonic saline and sodium bicarbonate solutions on cystic fibrosis sputum in vitro.BMC Pulm Med. 2021 Jul 12;21(1):225. doi: 10.1186/s12890-021-01599-z. BMC Pulm Med. 2021. PMID: 34253193 Free PMC article.
-
Secretion properties, clearance, and therapy in airway disease.Transl Respir Med. 2014 Mar 10;2:6. doi: 10.1186/2213-0802-2-6. eCollection 2014. Transl Respir Med. 2014. PMID: 25505698 Free PMC article. Review.
-
Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis.Clinics (Sao Paulo). 2009;64(12):1155-60. doi: 10.1590/S1807-59322009001200004. Clinics (Sao Paulo). 2009. PMID: 20037702 Free PMC article.
-
Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial.BMC Pulm Med. 2018 Jun 14;18(1):99. doi: 10.1186/s12890-018-0661-1. BMC Pulm Med. 2018. PMID: 29898704 Free PMC article. Clinical Trial.
-
Bronchiectasis, part 2: Management.J Respir Dis. 2008 Jan 1;29(1):20-25. J Respir Dis. 2008. PMID: 20046814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical